New York State Common Retirement Fund’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,720
| Closed | -$140K | – | 3136 |
|
|
2025
Q4 | $140K | Hold |
10,720
| – | – | ﹤0.01% | 2452 |
|
|
2025
Q3 | $78K | Hold |
10,720
| – | – | ﹤0.01% | 2767 |
|
|
2025
Q2 | $57.5K | Hold |
10,720
| – | – | ﹤0.01% | 2905 |
|
|
2025
Q1 | $57.2K | Hold |
10,720
| – | – | ﹤0.01% | 2725 |
|
|
2024
Q4 | $95.8K | Buy |
10,720
+4,300
| +67% | +$45.7K | ﹤0.01% | 2611 |
|
|
2024
Q3 | $70.7K | Sell |
6,420
-10,400
| -62% | -$116K | ﹤0.01% | 2743 |
|
|
2024
Q2 | $153K | Buy |
16,820
+4,175
| +33% | +$40.8K | ﹤0.01% | 2545 |
|
|
2024
Q1 | $178K | Buy |
12,645
+2,412
| +24% | +$30K | ﹤0.01% | 2501 |
|
|
2023
Q4 | $78.6K | Sell |
10,233
-48
| -0.5% | -$265 | ﹤0.01% | 2838 |
|
|
2023
Q3 | $76.7K | Buy |
10,281
+281
| +3% | +$2.4K | ﹤0.01% | 2851 |
|
|
2023
Q2 | $83.3K | Buy |
+10,000
| New | +$115K | ﹤0.01% | 2990 |
|
|
2021
Q3 | – | Sell |
-24
| Closed | – | – | 3341 |
|
|
2021
Q2 | $0 | Sell |
24
-2,726
| -99% | -$35.4K | ﹤0.01% | 3549 |
|
|
2021
Q1 | $48K | Hold |
2,750
| – | – | ﹤0.01% | 3226 |
|
|
2020
Q4 | $35K | Hold |
2,750
| – | – | ﹤0.01% | 3226 |
|
|
2020
Q3 | $102K | Hold |
2,750
| – | – | ﹤0.01% | 2910 |
|
|
2020
Q2 | $106K | Buy |
+2,750
| New | +$97.9K | ﹤0.01% | 2914 |
|
|
2016
Q3 | – | Sell |
-28
| Closed | -$6K | – | 3136 |
|
|
2016
Q2 | $6K | Sell |
28
-65
| -70% | -$19.6K | ﹤0.01% | 3179 |
|
|
2016
Q1 | $28K | Hold |
93
| – | – | ﹤0.01% | 3104 |
|
|
2015
Q4 | $44K | Buy |
+93
| New | +$44.6K | ﹤0.01% | 3122 |
|
New York State Common Retirement Fund's ATXS Position: Q1 2026 in Review
New York State Common Retirement Fund sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 10,720 shares — an estimated $140K sold.
New York State Common Retirement Fund first reported a position in ATXS in Q4 2015 and held it in 19 quarters. The position peaked at $178K in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- New York State Common Retirement Fund reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- New York State Common Retirement Fund sold 10,720 Astria Therapeutics shares in Q1 2026, an estimated $140K.
- New York State Common Retirement Fund first reported a position in Astria Therapeutics in Q4 2015 and held it in 19 quarters.
- New York State Common Retirement Fund's Astria Therapeutics position peaked at $178K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.